Prescription drug · ANDA
Lisdexamfetamine dimesylate NDC 0781-2479
Lisdexamfetamine dimesylate 50 mg/1 · Capsule · Oral · Sandoz Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0781-2479-01 | 00781247901 | 100 CAPSULE in 1 BOTTLE (0781-2479-01)Marketed from Sep 16, 2025 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lisdexamfetamine dimesylate
- Generic name (nonproprietary)
- lisdexamfetamine dimesylate
- Active ingredients
- Lisdexamfetamine dimesylate — 50 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Sandoz Inc
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 202836
- Marketing start
- Listing expires
- DEA schedule
- CII
- Other FDA classes
- Central Nervous System Stimulation (Physiologic effect)
- Identifiers
- Product ID 0781-2479_a22afd43-11c4-47f1-ab4a-681f82b3c4b7SPL ID a22afd43-11c4-47f1-ab4a-681f82b3c4b7SPL set ID 808cce3b-eee8-4f58-8d8a-53a4ce79ae7cRxCUI 854830, 854834, 854838, 854842, 854846, 854850, 1593856UNII SJT761GEGSUPC 0307812480014, 0307812481011, 0307812478011, 0307812477014, 0307812479018
- Pharmacologic class
- Central Nervous System Stimulant
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400781247901followed by a unit qualifier and the quantityPackage 00781-2479-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Label details couldn’t be retrieved right now. Open the label on DailyMed.
Other NDCs under ANDA 202836
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Lisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 70 mg/1 | CapsuleOral | Sandoz Inc | 0781-2481 |
| Lisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 20 mg/1 | CapsuleOral | Sandoz Inc | 0781-2476 |
| Lisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 10 mg/1 | CapsuleOral | Sandoz Inc | 0781-2299 |
| Lisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 30 mg/1 | CapsuleOral | Sandoz Inc | 0781-2477 |
| Lisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 40 mg/1 | CapsuleOral | Sandoz Inc | 0781-2478 |
| Lisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 60 mg/1 | CapsuleOral | Sandoz Inc | 0781-2480 |